Cargando…
Coagulation factor with potential for the treatment of heart failure
Autores principales: | Cao, Yang, Lusis, Aldons J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747747/ https://www.ncbi.nlm.nih.gov/pubmed/36513961 http://dx.doi.org/10.1002/ctm2.1144 |
Ejemplares similares
-
Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?
por: Seam, Nitin, et al.
Publicado: (2014) -
Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE
por: Liang, Bo, et al.
Publicado: (2020) -
Genetic Dissection of Cardiac Remodeling in an Isoproterenol-Induced Heart Failure Mouse Model
por: Wang, Jessica Jen-Chu, et al.
Publicado: (2016) -
Comorbidity “depression” in heart failure — Potential target of patient education and self-management
por: De Vecchis, Renato, et al.
Publicado: (2017) -
Properdin (factor P) as a new target cleaved by factor XIa: Intrinsic coagulation at the crossroads with inflammation
por: Luo, Qi, et al.
Publicado: (2022)